Renal Osteodystrophy
- 3 August 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 321 (5) , 317-319
- https://doi.org/10.1056/nejm198908033210509
Abstract
Replacement of the kidney's excretory function by dialysis has prolonged life, but it has also revealed the extent and importance of the organ's endocrine function. Lacking the kidney's endocrine contributions, patients undergoing long-term maintenance dialysis have considerable morbidity and mortality. Renal osteodystrophy, which is related to the diminished production of 1,25-dihydroxyvitamin D (1,25D), is one abnormality that results from the disturbed endocrine function of failing kidneys. Current research is attempting to unravel the pathogenetic events and underlying mechanisms of uremic osteodystrophy. These include, in addition to the increased excretion of phosphate per nephron and the impaired production of 1,25D, the . . .Keywords
This publication has 6 references indexed in Scilit:
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Control of Serum Phosphorus in UremiaNew England Journal of Medicine, 1989
- 1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trialKidney International, 1989
- Use of the Deferoxamine Infusion Test in the Diagnosis of Aluminum-Related OsteodystrophyAnnals of Internal Medicine, 1984
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- Bone histology in incipient and advanced renal failureKidney International, 1976